{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:26Z","timestamp":1792796786879,"version":"4.5.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10980-8","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:14:15Z","timestamp":1757409255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring LRP-1 in the liver-brain axis: implications for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-4180","authenticated-orcid":false,"given":"Vivek Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"2","key":"10980_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5535\/arm.22027","volume":"46","author":"JH Shin","year":"2022","unstructured":"Shin JH (2022) Dementia epidemiology fact sheet 2022. Ann Rehabil Med 46(2):53\u201359","journal-title":"Ann Rehabil Med"},{"key":"10980_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glac039","author":"DG Le Couteur","year":"2022","unstructured":"Le Couteur DG, Thillainadesan J (2022) What is an aging-related disease? An epidemiological perspective. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glac039","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10980_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J et al (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9:211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Signal Transduct Target Ther"},{"key":"10980_CR4","volume":"190","author":"NJ Hunt","year":"2022","unstructured":"Hunt NJ, Wahl D, Westwood LJ, Lockwood GP, Le Couteur DG, Cogger VC (2022) Targeting the liver in dementia and cognitive impairment: dietary macronutrients and diabetic therapeutics. Adv Drug Deliv Rev 190:114537","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10980_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112023","volume":"11","author":"A Lau","year":"2021","unstructured":"Lau A, Beheshti I, Modirrousta M, Kolesar TA, Goertzen AL, Ko JH (2021) Alzheimer\u2019s disease-related metabolic pattern in diverse forms of neurodegenerative diseases. Diagnostics 11(11):2023. https:\/\/doi.org\/10.3390\/diagnostics11112023","journal-title":"Diagnostics"},{"key":"10980_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.654509","volume":"13","author":"A Wi\u0119ckowska-Gacek","year":"2021","unstructured":"Wi\u0119ckowska-Gacek A, Mietelska-Porowska A, Chutora\u0144ski D, Wydrych M, D\u0142ugosz J, Wojda U (2021) Western diet induces impairment of liver-brain axis accelerating neuroinflammation and amyloid pathology in Alzheimer\u2019s disease. Front Aging Neurosci 13:654509. https:\/\/doi.org\/10.3389\/fnagi.2021.654509","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10980_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.4103\/NRR.NRR-D-23-01403","volume":"20","author":"M Hayat","year":"2025","unstructured":"Hayat M, Syed RA, Qaiser H et al (2025) Decoding molecular mechanisms: brain aging and Alzheimer\u2019s disease. Neural Regen Res 20(8):2279\u20132299. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01403","journal-title":"Neural Regen Res"},{"key":"10980_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn1809","volume":"7","author":"SN Burke","year":"2006","unstructured":"Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30\u201340","journal-title":"Nat Rev Neurosci"},{"key":"10980_CR9","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","volume":"99","author":"RI Scahill","year":"2002","unstructured":"Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer\u2019s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A 99:4703\u20134707","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10980_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00174","volume":"11","author":"LD Estrada","year":"2019","unstructured":"Estrada LD, Ahumada P, Cabrera D, Arab JP (2019) Liver dysfunction as a novel player in Alzheimer\u2019s progression: looking outside the brain. Front Aging Neurosci 11:174. https:\/\/doi.org\/10.3389\/fnagi.2019.00174","journal-title":"Front Aging Neurosci"},{"key":"10980_CR11","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1074\/jbc.M116.761189","volume":"292","author":"J Brito-Moreira","year":"2017","unstructured":"Brito-Moreira J, Lourenco MV, Oliveira MM et al (2017) Interaction of amyloid-\u03b2 (A\u03b2) oligomers with neurexin 2\u03b1 and neuroligin 1 mediates synapse damage and memory loss in mice. J Biol Chem 292:7327\u20137337. https:\/\/doi.org\/10.1074\/jbc.M116.761189","journal-title":"J Biol Chem"},{"key":"10980_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fncel.2018.00473","volume":"12","author":"S Ziegler-Waldkirch","year":"2018","unstructured":"Ziegler-Waldkirch S, Meyer-Luehmann M (2018) The role of glial cells and synapse loss in mouse models of Alzheimer\u2019s disease. Front Cell Neurosci 12:473. https:\/\/doi.org\/10.3389\/fncel.2018.00473","journal-title":"Front Cell Neurosci"},{"key":"10980_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian DY, Wang YJ (2020) Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener 9:16. https:\/\/doi.org\/10.1186\/s40035-020-00195-1","journal-title":"Transl Neurodegener"},{"key":"10980_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-052215-105147","volume":"68","author":"WV Graham","year":"2017","unstructured":"Graham WV, Bonito-Oliva A, Sakmar TP (2017) Update on Alzheimer\u2019s disease therapy and prevention strategies. Annu Rev Med 68:413\u2013430. https:\/\/doi.org\/10.1146\/annurev-med-052215-105147","journal-title":"Annu Rev Med"},{"key":"10980_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci 12:25. https:\/\/doi.org\/10.3389\/fnins.2018.00025","journal-title":"Front Neurosci"},{"issue":"11","key":"10980_CR16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/cells12111517","volume":"12","author":"J Fraile-Ramos","year":"2023","unstructured":"Fraile-Ramos J, Garrit A, Reig-Vilallonga J, Gim\u00e9nez-Llort L (2023) Hepatic oxi-inflammation and neophobia as potential liver\u2013brain axis targets for Alzheimer\u2019s disease and aging, with strong sensitivity to sex, isolation, and obesity. Cells 12(11):1517. https:\/\/doi.org\/10.3390\/cells12111517","journal-title":"Cells"},{"issue":"6","key":"10980_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-023-02575-5","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, He CY, Tian DY et al (2023) Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 145(6):717\u2013731. https:\/\/doi.org\/10.1007\/s00401-023-02575-5","journal-title":"Acta Neuropathol"},{"key":"10980_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113306","volume":"19","author":"A Tumminia","year":"2018","unstructured":"Tumminia A, Vinciguerra F, Parisi M, Frittitta L (2018) Type 2 diabetes mellitus and Alzheimer\u2019s disease: role of insulin signalling and therapeutic implications. Int J Mol Sci 19:3306. https:\/\/doi.org\/10.3390\/ijms19113306","journal-title":"Int J Mol Sci"},{"key":"10980_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-180910","volume":"68","author":"G Paroni","year":"2019","unstructured":"Paroni G, Bisceglia P, Seripa D (2019) Understanding the amyloid hypothesis in Alzheimer\u2019s disease. J Alzheimers Dis 68:493\u2013510. https:\/\/doi.org\/10.3233\/JAD-180910","journal-title":"J Alzheimers Dis"},{"key":"10980_CR20","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170119151923","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E (2017) The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr Neuropharmacol 15:926\u2013935. https:\/\/doi.org\/10.2174\/1570159X15666170119151923","journal-title":"Curr Neuropharmacol"},{"key":"10980_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jlb.4A1217-568R","volume":"106","author":"S Wang","year":"2019","unstructured":"Wang S, Colonna M (2019) Microglia in Alzheimer\u2019s disease: a target for immunotherapy. J Leukoc Biol 106:219\u2013227. https:\/\/doi.org\/10.1002\/jlb.4A1217-568R","journal-title":"J Leukoc Biol"},{"key":"10980_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103639","author":"NH Almohmadi","year":"2025","unstructured":"Almohmadi NH, Al-Kuraishy HM, Albuhadily AK et al (2025) Alzheimer disease: Amyloid peptide controversies and challenges of anti-A\u03b2 immunotherapy. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1016\/j.jpet.2025.103639","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10980_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00849-6","volume":"20","author":"D Song","year":"2025","unstructured":"Song D, Li Y, Yang LL, Luo YX, Yao XQ (2025) Bridging systemic metabolic dysfunction and Alzheimer\u2019s disease: the liver interface. Mol Neurodegener 20(1):61. https:\/\/doi.org\/10.1186\/s13024-025-00849-6","journal-title":"Mol Neurodegener"},{"issue":"20","key":"10980_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204298","volume":"14","author":"Z Huang","year":"2022","unstructured":"Huang Z, Lin HW, Zhang Q, Zong X (2022) Targeting Alzheimer\u2019s disease: the critical crosstalk between the liver and brain. Nutrients 14(20):4298. https:\/\/doi.org\/10.3390\/nu14204298","journal-title":"Nutrients"},{"issue":"3","key":"10980_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4103\/1673-5374.289778","volume":"20","author":"B Wu","year":"2025","unstructured":"Wu B, Liu Y, Li H et al (2025) Liver as a new target organ in Alzheimer\u2019s disease: insight from cholesterol metabolism and its role in amyloid-beta clearance. Neural Regen Res 20(3):695\u2013714. https:\/\/doi.org\/10.4103\/1673-5374.289778","journal-title":"Neural Regen Res"},{"issue":"6","key":"10980_CR26","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/WNL.0000000000200853","volume":"99","author":"Y Shang","year":"2022","unstructured":"Shang Y, Widman L, Hagstr\u00f6m H (2022) Nonalcoholic fatty liver disease and risk of dementia: a population-based cohort study. Neurology 99(6):e574\u2013e582","journal-title":"Neurology"},{"key":"10980_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.748888","volume":"13","author":"L Lampignano","year":"2021","unstructured":"Lampignano L, Donghia R, Griseta C et al (2021) Liver health and dementia in an Italian older population: findings from the Salus in Apulia Study. Front Aging Neurosci 13:748888. https:\/\/doi.org\/10.3389\/fnagi.2021.748888","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"10980_CR28","doi-asserted-by":"publisher","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","volume":"2","author":"K Nho","year":"2019","unstructured":"Nho K, Kueider-Paisley A, Ahmad S et al (2019) Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open 2(7):e197978","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10980_CR29","volume":"6","author":"V Solfrizzi","year":"2020","unstructured":"Solfrizzi V, Scafato E, Custodero C et al (2020) Liver fibrosis score, physical frailty, and the risk of dementia in older adults: the Italian longitudinal study on aging. Alzheimers Dement (N Y) 6(1):e12065","journal-title":"Alzheimers Dement (N Y)"},{"issue":"7","key":"10980_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res 58(7):1267\u20131281. https:\/\/doi.org\/10.1194\/jlr.R075796","journal-title":"J Lipid Res"},{"key":"10980_CR31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD et al (2007) Clearance of amyloid-\u03b2 by circulating lipoprotein receptors. Nat Med 13:1029\u20131031","journal-title":"Nat Med"},{"issue":"1","key":"10980_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2024.100012","volume":"12","author":"JW Kim","year":"2025","unstructured":"Kim JW, Byun MS, Yi D et al (2025) Liver function and Alzheimer\u2019s brain pathologies: a longitudinal study: liver and Alzheimer\u2019s pathologies. J Prev Alzheimers Dis 12(1):100012. https:\/\/doi.org\/10.1016\/j.tjpad.2024.100012","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"10980_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1124\/mol.107.036701","volume":"72","author":"C Tamaki","year":"2007","unstructured":"Tamaki C, Ohtsuki S, Terasaki T (2007) Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1\u201340) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Mol Pharmacol 72(4):850\u2013855. https:\/\/doi.org\/10.1124\/mol.107.036701","journal-title":"Mol Pharmacol"},{"key":"10980_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11011-015-9752-3","volume":"31","author":"S Hjerrild","year":"2016","unstructured":"Hjerrild S, Renvillard SG, Leutscher P et al (2016) Reduced cerebral cortical thickness in non-cirrhotic patients with hepatitis C. Metab Brain Dis 31:311\u2013319","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10980_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaneurol.2017.3229","volume":"75","author":"G Weinstein","year":"2018","unstructured":"Weinstein G, Zelber-Sagi S, Preis SR et al (2018) Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the Framingham Study. JAMA Neurol 75(1):97\u2013104. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3229","journal-title":"JAMA Neurol"},{"issue":"6","key":"10980_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001358","volume":"19","author":"V Lam","year":"2021","unstructured":"Lam V et al (2021) Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype. PLoS Biol 19(6):e3001358. https:\/\/doi.org\/10.1371\/journal.pbio.3001358","journal-title":"PLoS Biol"},{"key":"10980_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G (2014) The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front Aging Neurosci 6:93. https:\/\/doi.org\/10.3389\/fnagi.2014.00093","journal-title":"Front Aging Neurosci"},{"key":"10980_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ibneur.2025.01.004","volume":"18","author":"S Darabi","year":"2025","unstructured":"Darabi S, Gorgich EAC, Moradi F, Rustamzadeh A (2025) Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer\u2019s disease: where are our knowledge. IBRO Neurosci Rep 18:191\u2013199","journal-title":"IBRO Neurosci Rep"},{"issue":"19","key":"10980_CR39","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1073\/pnas.1116934109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Gupta A, Valli RK et al (2012) Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 109(19):7318\u20137323. https:\/\/doi.org\/10.1073\/pnas.1116934109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10980_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00051","volume":"6","author":"N Potere","year":"2019","unstructured":"Potere N, Del Buono MG, Mauro AG et al (2019) Low-density lipoprotein receptor-related protein-1 in cardiac inflammation and infarct healing. Front Cardiovasc Med 6:51. https:\/\/doi.org\/10.3389\/fcvm.2019.00051","journal-title":"Front Cardiovasc Med"},{"key":"10980_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fcvm.2017.00034","volume":"4","author":"H Mao","year":"2017","unstructured":"Mao H, Xie L, Pi X (2017) Low-density lipoprotein receptor-related protein-1 signalling in angiogenesis. Front Cardiovasc Med 4:34. https:\/\/doi.org\/10.3389\/fcvm.2017.00034","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10980_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0092-8674(92)90511-A","volume":"71","author":"J Herz","year":"1992","unstructured":"Herz J, Clouthier DE, Hammer RE (1992) LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71(3):411\u2013421. https:\/\/doi.org\/10.1016\/0092-8674(92)90511-A","journal-title":"Cell"},{"issue":"1","key":"10980_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajpath.2013.10.018","volume":"184","author":"SL Gonias","year":"2014","unstructured":"Gonias SL, Campana WM (2014) LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am J Pathol 184(1):18\u201327. https:\/\/doi.org\/10.1016\/j.ajpath.2013.10.018","journal-title":"Am J Pathol"},{"key":"10980_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-17","volume":"4","author":"Q Liu","year":"2009","unstructured":"Liu Q, Zhang J, Tran H et al (2009) LRP-1 shedding in human brain: roles of ADAM10 and ADAM17. Mol Neurodegener 4:17. https:\/\/doi.org\/10.1186\/1750-1326-4-17","journal-title":"Mol Neurodegener"},{"issue":"7","key":"10980_CR45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/pharmaceutics16070948","volume":"16","author":"S Petralla","year":"2024","unstructured":"Petralla S, Panayotova M, Franchina E et al (2024) Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in Alzheimer\u2019s disease. Pharmaceutics 16(7):948. https:\/\/doi.org\/10.3390\/pharmaceutics16070948","journal-title":"Pharmaceutics"},{"key":"10980_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00269","volume":"3","author":"C Spuch","year":"2012","unstructured":"Spuch C, Ortolano S, Navarro C (2012) LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer\u2019s disease. Front Physiol 3:269. https:\/\/doi.org\/10.3389\/fphys.2012.00269","journal-title":"Front Physiol"},{"issue":"1","key":"10980_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01529-1","volume":"16","author":"L Preis","year":"2024","unstructured":"Preis L, Villringer K, Brosseron F et al (2024) Assessing blood-brain barrier dysfunction and its association with Alzheimer\u2019s pathology, cognitive impairment and neuroinflammation. Alzheimers Res Ther 16(1):172. https:\/\/doi.org\/10.1186\/s13195-024-01529-1","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10980_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD et al (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85(2):296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032","journal-title":"Neuron"},{"key":"10980_CR49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","volume":"12","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12:623\u2013635","journal-title":"Nat Rev Immunol"},{"key":"10980_CR50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/156720510793499066","volume":"7","author":"T Pflanzner","year":"2010","unstructured":"Pflanzner T, Kuhlmann CR, Pietrzik CU (2010) Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Curr Alzheimer Res 7:578\u2013590","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"10980_CR51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP et al (2012) Multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122(4):1377\u20131392","journal-title":"J Clin Invest"},{"key":"10980_CR52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2016.01.041","volume":"322","author":"YX Guo","year":"2016","unstructured":"Guo YX, He LY, Zhang M et al (2016) 1,25-dihydroxyvitamin D3 regulates expression of LRP-1 and RAGE in vitro and in vivo, enhancing A\u03b21-40 brain-to-blood efflux and peripheral uptake transport. Neuroscience 322:28\u201338","journal-title":"Neuroscience"},{"issue":"1","key":"10980_CR53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J et al (2016) Endothelial LRP-1 transports amyloid-\u03b21-42 across the blood-brain barrier. J Clin Invest 126(1):123\u2013136","journal-title":"J Clin Invest"},{"issue":"3","key":"10980_CR54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","volume":"17","author":"D Kuhnke","year":"2007","unstructured":"Kuhnke D, Jedlitschky G, Grube M et al (2007) MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer\u2019s amyloid-beta peptides\u2014implications for the mechanisms of A\u03b2 clearance at the blood-brain barrier. Brain Pathol 17(3):347\u2013353","journal-title":"Brain Pathol"},{"key":"10980_CR55","volume":"5","author":"L Park","year":"2014","unstructured":"Park L, Kook SY, Park JC et al (2014) A\u03b21-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling. Cell Death Dis 5:e1199","journal-title":"Cell Death Dis"},{"key":"10980_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1515\/revneuro-2015-0069","volume":"27","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Li D, Zhao J et al (2016) The role of the low-density lipoprotein receptor-related protein 1 (LRP-1) in regulating blood-brain barrier integrity. Rev Neurosci 27:623\u2013634. https:\/\/doi.org\/10.1515\/revneuro-2015-0069","journal-title":"Rev Neurosci"},{"issue":"6","key":"10980_CR57","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2011.03.013","volume":"55","author":"CI \u00d8ie","year":"2011","unstructured":"\u00d8ie CI, Appa RS, Hilden I et al (2011) Rat liver sinusoidal endothelial cells (LSECs) express functional low-density lipoprotein receptor-related protein-1 (LRP-1). J Hepatol 55(6):1346\u20131352","journal-title":"J Hepatol"},{"issue":"1","key":"10980_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","volume":"136","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Deane R, Zlokovic BV (2012) Low-density lipoprotein receptor-related protein 1: a physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities. Pharmacol Ther 136(1):94\u2013105. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.008","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10980_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2014.10.016","volume":"159","author":"B De Strooper","year":"2014","unstructured":"De Strooper B (2014) Lessons from a failed \u03b3-secretase Alzheimer trial. Cell 159(4):721\u2013726. https:\/\/doi.org\/10.1016\/j.cell.2014.10.016","journal-title":"Cell"},{"key":"10980_CR60","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1038\/s41467-023-36645-9","volume":"14","author":"J Lee","year":"2023","unstructured":"Lee J, Lee H, Lee H et al (2023) ANKS1A regulates LDL receptor-related protein 1 (LRP-1)-mediated cerebrovascular clearance in brain endothelial cells. Nat Commun 14:8463. https:\/\/doi.org\/10.1038\/s41467-023-36645-9","journal-title":"Nat Commun"},{"key":"10980_CR61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202207","author":"AM Nikolakopoulou","year":"2021","unstructured":"Nikolakopoulou AM, Wang Y, Ma Q et al (2021) Endothelial LRP-1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20202207","journal-title":"J Exp Med"},{"key":"10980_CR62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12987-021-00260-5","volume":"18","author":"SE Storck","year":"2021","unstructured":"Storck SE, Kurtyka M, Pietrzik CU (2021) Brain endothelial LRP-1 maintains blood-brain barrier integrity. Fluids Barriers CNS 18:27","journal-title":"Fluids Barriers CNS"},{"key":"10980_CR63","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"Wilcox G (2005) Insulin and insulin resistance. Clin Biochem Rev 26:19\u201339","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"10980_CR64","volume":"24","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Hwang J, Son SU et al (2023) How can insulin resistance cause Alzheimer\u2019s disease? Int J Mol Sci 24(4):3506","journal-title":"Int J Mol Sci"},{"key":"10980_CR65","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"JL Milstein","year":"2021","unstructured":"Milstein JL, Ferris HA (2021) The brain as an insulin-sensitive metabolic organ. Mol Metab 52:101234","journal-title":"Mol Metab"},{"issue":"9","key":"10980_CR66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12866","volume":"24","author":"I Pomytkin","year":"2018","unstructured":"Pomytkin I, Costa-Nunes JP, Kasatkin V et al (2018) Insulin receptor in the brain: mechanisms of activation and the role in CNS pathology and treatment. CNS Neurosci Ther 24(9):763\u2013774","journal-title":"CNS Neurosci Ther"},{"key":"10980_CR67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL et al (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14:168\u2013181","journal-title":"Nat Rev Neurol"},{"key":"10980_CR68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2016.04.002","volume":"7","author":"Y Ding","year":"2016","unstructured":"Ding Y, Xian X, Holland WL et al (2016) Low-density lipoprotein receptor-related protein-1 protects against hepatic insulin resistance and hepatic steatosis. EBioMedicine 7:135\u2013145","journal-title":"EBioMedicine"},{"issue":"50","key":"10980_CR69","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","volume":"30","author":"Q Liu","year":"2010","unstructured":"Liu Q, Trotter J, Zhang J et al (2010) Neuronal LRP-1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 30(50):17068\u201317078","journal-title":"J Neurosci"},{"issue":"1","key":"10980_CR70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1074\/jbc.M109.040428","volume":"285","author":"MP Jedrychowski","year":"2010","unstructured":"Jedrychowski MP, Gartner CA, Gygi SP et al (2010) Proteomic analysis of GLUT4 storage vesicles reveals LRP-1 to be an important vesicle component and target of insulin signaling. J Biol Chem 285(1):104\u2013114. https:\/\/doi.org\/10.1074\/jbc.M109.040428","journal-title":"J Biol Chem"},{"issue":"12","key":"10980_CR71","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/17460441.2019.1659242","volume":"14","author":"M Konstantinidou","year":"2019","unstructured":"Konstantinidou M, Li J, Zhang B et al (2019) PROTACs \u2013 a game-changing technology. Expert Opin Drug Discov 14(12):1255\u20131268","journal-title":"Expert Opin Drug Discov"},{"issue":"14","key":"10980_CR72","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","volume":"35","author":"CC Liu","year":"2015","unstructured":"Liu CC, Hu J, Tsai CW et al (2015) Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci 35(14):5851\u20135859. https:\/\/doi.org\/10.1523\/JNEUROSCI.5180-14.2015","journal-title":"J Neurosci"},{"key":"10980_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.103390","volume":"99","author":"CC Gali","year":"2019","unstructured":"Gali CC, Fanaee-Danesh E, Zandl-Lang M et al (2019) Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-\u03b2 in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice. Mol Cell Neurosci 99:103390. https:\/\/doi.org\/10.1016\/j.mcn.2019.103390","journal-title":"Mol Cell Neurosci"},{"key":"10980_CR74","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ibneur.2025.05.005","volume":"18","author":"P Kamila","year":"2025","unstructured":"Kamila P, Kar K, Chowdhury S et al (2025) Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments. IBRO Neurosci Rep 18:771\u2013782. https:\/\/doi.org\/10.1016\/j.ibneur.2025.05.005","journal-title":"IBRO Neurosci Rep"},{"issue":"5","key":"10980_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050524","volume":"9","author":"IG Onyango","year":"2021","unstructured":"Onyango IG, Jauregui GV, \u010carn\u00e1 M et al (2021) Neuroinflammation in Alzheimer\u2019s disease. Biomedicines 9(5):524. https:\/\/doi.org\/10.3390\/biomedicines9050524","journal-title":"Biomedicines"},{"key":"10980_CR76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2021.12.071","volume":"590","author":"H Jiao","year":"2022","unstructured":"Jiao H, Jia J (2022) Ginsenoside compound K acts via LRP-1 to alleviate amyloid \u03b242-induced neuroinflammation in microglia by suppressing NF-\u03baB. Biochem Biophys Res Commun 590:14\u201319","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10980_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P et al (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46(1):1\u201317","journal-title":"Inflammation"},{"issue":"1","key":"10980_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0772-7","volume":"13","author":"L Yang","year":"2016","unstructured":"Yang L, Liu CC, Zheng H et al (2016) LRP1 modulates the microglial immune response via regulation of JNK and NF-\u03baB signaling pathways. J Neuroinflammation 13(1):304. https:\/\/doi.org\/10.1186\/s12974-016-0772-7","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10980_CR79","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.109.202051","volume":"30","author":"PG Yancey","year":"2010","unstructured":"Yancey PG, Blakemore J, Ding L et al (2010) Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 30(4):787\u2013795","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10980_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000898","volume":"6","author":"P Garc\u00eda-Fern\u00e1ndez","year":"2021","unstructured":"Garc\u00eda-Fern\u00e1ndez P, \u00dc\u00e7eyler N, Sommer C (2021) From the low-density lipoprotein receptor-related protein 1 to neuropathic pain: a potentially novel target. Pain Rep 6(1):e898. https:\/\/doi.org\/10.1097\/PR9.0000000000000898","journal-title":"Pain Rep"},{"issue":"1","key":"10980_CR81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09168451.2017.1399788","volume":"82","author":"HX Fei","year":"2018","unstructured":"Fei HX, Zhang YB, Liu T et al (2018) Neuroprotective effect of formononetin in ameliorating learning and memory impairment in a mouse model of Alzheimer\u2019s disease. Biosci Biotechnol Biochem 82(1):57\u201364","journal-title":"Biosci Biotechnol Biochem"},{"issue":"39","key":"10980_CR82","doi-asserted-by":"publisher","first-page":"69370","DOI":"10.18632\/oncotarget.20628","volume":"8","author":"X Wen","year":"2017","unstructured":"Wen X, Xiao L, Zhong Z et al (2017) Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1\/M2 polarization of microglial cells. Oncotarget 8(39):69370\u201369385. https:\/\/doi.org\/10.18632\/oncotarget.20628","journal-title":"Oncotarget"},{"key":"10980_CR83","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00136","volume":"7","author":"A Ramanathan","year":"2015","unstructured":"Ramanathan A, Nelson AR, Sagare AP et al (2015) Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer\u2019s disease: the role, regulation and restoration of LRP1. Front Aging Neurosci 7:136","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10980_CR84","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1007\/s12035-019-1594-2","volume":"56","author":"B Van Gool","year":"2019","unstructured":"Van Gool B, Storck SE, Reekmans SM et al (2019) LRP1 Has a Predominant Role in Production over Clearance of A\u03b2 in a Mouse Model of Alzheimer\u2019s Disease. Mol Neurobiol 56(10):7234\u20137245","journal-title":"Mol Neurobiol"},{"key":"10980_CR85","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12:723\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"10980_CR86","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","volume":"38","author":"JB Mackic","year":"2002","unstructured":"Mackic JB, Bading J, Ghiso J et al (2002) Circulating amyloid-beta peptide crosses the blood\u2013brain barrier in aged monkeys and contributes to Alzheimer\u2019s disease lesions. Vascul Pharmacol 38:303\u2013313","journal-title":"Vascul Pharmacol"},{"key":"10980_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/cam.2.2.6374","volume":"2","author":"S Dedieu","year":"2008","unstructured":"Dedieu S, Langlois B (2008) LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells. Cell Adhes Migr 2:77\u201380. https:\/\/doi.org\/10.4161\/cam.2.2.6374","journal-title":"Cell Adhes Migr"},{"issue":"4","key":"10980_CR88","volume":"8","author":"AN Tackett","year":"2023","unstructured":"Tackett AN, Duffy LK (2023) A connectivity between LRP-1 and Alzheimer\u2019s disease: modulating the transport and clearance of tau and A\u03b2 clearance from the brain to the liver. Adv Clin Toxicol 8(4):000281","journal-title":"Adv Clin Toxicol"},{"issue":"3","key":"10980_CR89","volume":"28","author":"KBE Moore","year":"2023","unstructured":"Moore KBE, Hung TJ, Fortin JS (2023) Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related tauopathies. Drug Discov Today 28(3):103487","journal-title":"Drug Discov Today"},{"issue":"12","key":"10980_CR90","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/molecules29122812","volume":"29","author":"J Yang","year":"2024","unstructured":"Yang J, Zhi W, Wang L (2024) Role of tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review. Molecules 29(12):2812. https:\/\/doi.org\/10.3390\/molecules29122812","journal-title":"Molecules"},{"key":"10980_CR91","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E et al (2020) LRP-1 is a master regulator of tau uptake and spread. Nature 580:381\u2013385. https:\/\/doi.org\/10.1038\/s41586-020-2156-5","journal-title":"Nature"},{"key":"10980_CR92","doi-asserted-by":"publisher","unstructured":"Cooper JM, Lathuiliere A, Migliorini M et al (2020) Regulation of tau internalization, degradation, and seeding by LRP-1 reveals multiple pathways for tau catabolism. bioRxiv. https:\/\/doi.org\/10.1101\/2020.11.17.386581","DOI":"10.1101\/2020.11.17.386581"},{"issue":"23","key":"10980_CR93","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232763","volume":"12","author":"R Pluta","year":"2023","unstructured":"Pluta R, Kocki J, Bogucki J et al (2023) LRP-1 and RAGE genes transporting amyloid and tau protein in the hippocampal CA3 area in an ischemic model of Alzheimer\u2019s disease with 2-year survival. Cells 12(23):2763","journal-title":"Cells"},{"key":"10980_CR94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, Lathuiliere A, Migliorini M et al (2021) Regulation of tau internalization, degradation, and seeding by LRP-1 reveals multiple pathways for tau catabolism. J Biol Chem 296:100715","journal-title":"J Biol Chem"},{"issue":"12","key":"10980_CR95","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","volume":"57","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M et al (2020) Gut microbiota and dysbiosis in Alzheimer\u2019s disease: implications for pathogenesis and treatment. Mol Neurobiol 57(12):5026\u20135043","journal-title":"Mol Neurobiol"},{"issue":"20","key":"10980_CR96","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.3390\/nu15204445","volume":"15","author":"X Zhou","year":"2023","unstructured":"Zhou X, Lian P, Liu H et al (2023) Causal associations between gut microbiota and different types of dyslipidemia: a two-sample Mendelian randomization study. Nutrients 15(20):4445","journal-title":"Nutrients"},{"key":"10980_CR97","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nut.2012.07.017","volume":"29","author":"T Arora","year":"2013","unstructured":"Arora T, Singh S, Sharma RK (2013) Probiotics: interaction with gut microbiome and antiobesity potential. Nutr 29:591\u2013596","journal-title":"Nutr"},{"key":"10980_CR98","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","volume":"11","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E (2019) The role of the microbiome in NAFLD and NASH. EMBO Mol Med 11:e9302","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10980_CR99","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14161","volume":"39","author":"G Weinstein","year":"2019","unstructured":"Weinstein G, Davis-Plourde K, Himali JJ et al (2019) Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: the Framingham Study. Liver Int 39(9):1713\u20131721","journal-title":"Liver Int"},{"issue":"1","key":"10980_CR100","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-022-00836-0","volume":"12","author":"SY Cheon","year":"2022","unstructured":"Cheon SY, Song J (2022) Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell Biosci 12(1):99","journal-title":"Cell Biosci"},{"key":"10980_CR101","first-page":"27","volume":"11","author":"R Karbalaei","year":"2018","unstructured":"Karbalaei R, Allahyari M, Rezaei-Tavirani M et al (2018) Protein-protein interaction analysis of Alzheimer\u2019s disease and NAFLD based on systems biology methods unhide common ancestor pathways. Gastroenterol Hepatol Bed Bench 11:27\u201333","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10980_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","volume":"13","author":"DG Kim","year":"2016","unstructured":"Kim DG, Krenz A, Toussaint LE et al (2016) Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation 13:1. https:\/\/doi.org\/10.1186\/s12974-015-0467-5","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10980_CR103","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3350\/cmh.2021.0332","volume":"28","author":"S Jeong","year":"2022","unstructured":"Jeong S, Oh YH, Choi S et al (2022) Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults. Clin Mol Hepatol 28(3):510\u2013521. https:\/\/doi.org\/10.3350\/cmh.2021.0332","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10980_CR104","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3233\/JAD-220343","volume":"88","author":"SW Han","year":"2022","unstructured":"Han SW, Park YH, Jang ES et al (2022) Implications of liver enzymes in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis 88(4):1371\u20131376. https:\/\/doi.org\/10.3233\/JAD-220343","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10980_CR105","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/07388551.2014.889077","volume":"35","author":"SB Choi","year":"2015","unstructured":"Choi SB, Lew LC, Yeo SK et al (2015) Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and hyde scenario. Crit Rev Biotechnol 35(3):392\u2013401. https:\/\/doi.org\/10.3109\/07388551.2014.889077","journal-title":"Crit Rev Biotechnol"},{"issue":"2","key":"10980_CR106","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/diabetology3020026","volume":"3","author":"M Kouvari","year":"2022","unstructured":"Kouvari M, Sergi D, D\u2019Cunha NM et al (2022) Is non-alcoholic fatty liver disease connected with cognition? The complex interplay between liver and brain. Diabetology 3(2):355\u2013363. https:\/\/doi.org\/10.3390\/diabetology3020026","journal-title":"Diabetology"},{"issue":"25","key":"10980_CR107","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.1074\/jbc.RA118.003105","volume":"293","author":"AN Hamlin","year":"2018","unstructured":"Hamlin AN, Chinnarasu S, Ding Y et al (2018) Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression. J Biol Chem 293(25):9674\u20139684. https:\/\/doi.org\/10.1074\/jbc.RA118.003105","journal-title":"J Biol Chem"},{"issue":"32","key":"10980_CR108","doi-asserted-by":"publisher","first-page":"16610","DOI":"10.1074\/jbc.M116.738414","volume":"291","author":"AN Hamlin","year":"2016","unstructured":"Hamlin AN, Basford JE, Jaeschke A et al (2016) LRP-1 protein deficiency exacerbates palmitate-induced steatosis and toxicity in hepatocytes. J Biol Chem 291(32):16610\u201316619. https:\/\/doi.org\/10.1074\/jbc.M116.738414","journal-title":"J Biol Chem"},{"issue":"22","key":"10980_CR109","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003307","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan X, Stamova B, Jin LW et al (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87(22):2324\u20132332. https:\/\/doi.org\/10.1212\/WNL.0000000000003307","journal-title":"Neurology"},{"key":"10980_CR110","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fnagi.2017.00407","volume":"9","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Cong L, Lukiw WJ (2017) Lipopolysaccharide (LPS) accumulates in neocortical neurons of Alzheimer\u2019s disease (AD) brain and impairs transcription in human neuronal-glial primary co-cultures. Front Aging Neurosci 9:407. https:\/\/doi.org\/10.3389\/fnagi.2017.00407","journal-title":"Front Aging Neurosci"},{"key":"10980_CR111","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-021-00241-4","volume":"10","author":"HS Kim","year":"2021","unstructured":"Kim HS, Kim S, Shin SJ et al (2021) Gram-negative bacteria and their lipopolysaccharides in Alzheimer\u2019s disease: pathologic roles and therapeutic implications. Transl Neurodegener 10:49. https:\/\/doi.org\/10.1186\/s40035-021-00241-4","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10980_CR112","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-024-00460-x","volume":"19","author":"YX Luo","year":"2024","unstructured":"Luo YX, Yang LL, Yao XQ (2024) Gut microbiota-host lipid crosstalk in Alzheimer\u2019s disease: implications for disease progression and therapeutics. Mol Neurodegener 19(1):35. https:\/\/doi.org\/10.1186\/s13024-024-00460-x","journal-title":"Mol Neurodegener"},{"key":"10980_CR113","doi-asserted-by":"publisher","unstructured":"Strickland MR, Holtzman DM (2019) Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP-1. J Clin Invest 129(3):969\u2013971. https:\/\/doi.org\/10.1172\/JCI126631","DOI":"10.1172\/JCI126631"},{"issue":"1","key":"10980_CR114","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00514-1","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA et al (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72. https:\/\/doi.org\/10.1186\/s13024-022-00514-1","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10980_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010778","volume":"24","author":"M Pires","year":"2023","unstructured":"Pires M, Rego AC (2023) ApoE4 and Alzheimer\u2019s disease pathogenesis\u2014mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci 24(1):778. https:\/\/doi.org\/10.3390\/ijms24010778","journal-title":"Int J Mol Sci"},{"key":"10980_CR116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"TPV Huynh","year":"2019","unstructured":"Huynh TPV, Wang C, Tran AC et al (2019) Lack of hepatic apoE does not influence early A\u03b2 deposition: observations from a new APOE knock-in model. Mol Neurodegener 14:37","journal-title":"Mol Neurodegener"},{"key":"10980_CR117","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY et al (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97:2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Arch Toxicol"},{"issue":"2","key":"10980_CR118","first-page":"32","volume":"8","author":"K Ranjana","year":"2012","unstructured":"Ranjana K, Negi R, Pande D et al (2012) Markers of oxidative stress in generalized anxiety psychiatric disorder: therapeutic implications. J Stress Physiol Biochem 8(2):32\u201338","journal-title":"J Stress Physiol Biochem"},{"issue":"1","key":"10980_CR119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11033-023-08439-y","volume":"51","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Beura SK, Sharma P et al (2024) Oxidative stress in Alzheimer\u2019s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep 51(1):48. https:\/\/doi.org\/10.1007\/s11033-023-08439-y","journal-title":"Mol Biol Rep"},{"key":"10980_CR120","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.11.013","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D et al (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464. https:\/\/doi.org\/10.1016\/j.redox.2017.11.013","journal-title":"Redox Biol"},{"issue":"11","key":"10980_CR121","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.08.011","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD et al (2010) Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain. Free Radic Biol Med 49(11):1798\u20131803. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.08.011","journal-title":"Free Radic Biol Med"},{"key":"10980_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101049","volume":"64","author":"DA Butterfield","year":"2020","unstructured":"Butterfield DA (2020) Brain lipid peroxidation and Alzheimer disease: synergy between the Butterfield and Mattson laboratories. Ageing Res Rev 64:101049. https:\/\/doi.org\/10.1016\/j.arr.2020.101049","journal-title":"Ageing Res Rev"},{"key":"10980_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.912896","volume":"16","author":"X Li","year":"2022","unstructured":"Li X, Zhang P, Li H et al (2022) The protective effects of zeaxanthin on amyloid-\u03b2 peptide 1\u201342-induced impairment of learning and memory ability in rats. Front Behav Neurosci 16:912896. https:\/\/doi.org\/10.3389\/fnbeh.2022.912896","journal-title":"Front Behav Neurosci"},{"issue":"5","key":"10980_CR124","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE et al (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27(5):909\u2013918","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10980_CR125","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","volume":"88","author":"AP Lillis","year":"2008","unstructured":"Lillis AP, Van Duyn LB, Murphy-Ullrich JE et al (2008) LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 88(3):887\u2013918","journal-title":"Physiol Rev"},{"key":"10980_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101941","volume":"84","author":"KC da Cruz Rodrigues","year":"2024","unstructured":"da Cruz Rodrigues KC, Kim SC, Uner AA et al (2024) LRP-1 in GABAergic neurons is a key link between obesity and memory function. Mol Metab 84:101941. https:\/\/doi.org\/10.1016\/j.molmet.2024.101941","journal-title":"Mol Metab"},{"key":"10980_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175756","volume":"951","author":"Y Ju","year":"2023","unstructured":"Ju Y, Gu L, Hu M et al (2023) Andrographolide exerts a neuroprotective effect by regulating the LRP-1-mediated PPAR\u03b3\/NF-\u03baB pathway. Eur J Pharmacol 951:175756. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175756","journal-title":"Eur J Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10980-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:04:46Z","timestamp":1766898286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10980-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10980"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10980-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Ethical approval was not applicable for this study as it did not involve human participants, animal subjects, or clinical trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"873"}}